Company intelligence / Profile preview

Birmingham Biotech

Birmingham, West Midlands, United Kingdom

Ownership: Private
Development stage: Other

Overview

Commercial-stage biotech developing drug-free barrier-based nasal, oral, and vaginal sprays using biomaterial technology for respiratory protection, allergy relief, and intimate care.

Therapeutic areas: ImmunologyWomen's HealthOtherInfectious DiseasesPulmonology
Modalities: Device
Industry: Consumable Medical Devices

Partnerships

University of Birmingham

Beyond the preview

Go deeper on Birmingham Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Birmingham Biotech.

Explore the full profile